Impact of the introduction of rotavirus vaccine on hospital admissions for diarrhea among children in Kenya: a controlled interrupted time-series analysis

GP Otieno, C Bottomley, S Khagayi… - Clinical Infectious …, 2020 - academic.oup.com
Abstract Background Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was
introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 …

Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis.

GP Otieno, C Bottomley, S Khagayi… - Clinical Infectious …, 2020 - search.ebscohost.com
Abstract Background Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was
introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 …

[PDF][PDF] Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

GP Otieno, C Bottomley, S Khagayi, I Adetifa, M Ngama… - 2019 - 116683.com
Background. Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in
Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A …

[HTML][HTML] Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

GP Otieno, C Bottomley, S Khagayi… - … Diseases: An Official …, 2020 - ncbi.nlm.nih.gov
Background Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in
Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A …

Impact of the introduction of rotavirus vaccine on hospital admissions for diarrhoea among children in Kenya: a controlled interrupted time series analysis

GP Otieno, C Bottomley, S Khagayi… - Clinical Infectious …, 2020 - wrap.warwick.ac.uk
Introduction Monovalent rotavirus vaccine, RotarixTM, was introduced in Kenya in July 2014,
is recommended to infants as oral doses at ages 6 and 10 weeks. A multi-site study was …

[PDF][PDF] Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

GP Otieno, C Bottomley, S Khagayi, I Adetifa, M Ngama… - 2019 - pdfs.semanticscholar.org
Background. Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in
Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A …

[PDF][PDF] Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

GP Otieno, C Bottomley, S Khagayi… - Clinical Infectious …, 2020 - academic.oup.com
Abstract Background Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was
introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 …

[PDF][PDF] Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

GP Otieno, C Bottomley, S Khagayi, I Adetifa, M Ngama… - 2019 - academia.edu
Background. Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in
Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A …

[PDF][PDF] Impact of the introduction of rotavirus vaccine on hospital admissions for diarrhoea among children in Kenya: A controlled interrupted time series analysis

GP Otieno, C Bottomley, S Khagayi, I Adetifa… - 2019 - core.ac.uk
Following the national introduction of the rotavirus vaccine in Kenya, our impact evaluation
across two surveillance sites indicates a substantial reduction in childhood hospitalisation …

Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

GP Otieno, C Bottomley, S Khagayi… - … publication of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in
Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A …